Complete Filing Data
Goldman Sachs BDC, Inc. reported Net Asset Value Per Share of 13 shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Goldman Sachs BDC, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | $119.3M | $62.9M | $195.9M | $55.0M | $192.4M | $176.1M |
| Other General And Administrative Expense | $4.6M | $4.5M | $4.3M | $4.4M | $3.4M | $2.9M |
| Operating Expenses | $180.0M | $176.5M | $204.8M | $136.2M | $139.9M | $98.6M |
| Income Tax Expense Benefit | $5.3M | $4.8M | $4.5M | $1.3M | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $24.7M | $39.3M | $31.6M | $37.1M | -$54.2M | $42.5M | $51.6M | $65.7M | $28.1M | -$7.5M | $18.7M | $40.2M | $38.0M |
| Other General And Administrative Expense | $1.2M | $1.3M | $1.0M | $1.0M | $1.0M | $1.1M | $1.1M | $1.0M | $1.1M | $1.0M | $1.1M | $1.1M | $793.0K |
| Operating Expenses | $45.4M | $45.6M | $46.0M | $40.7M | $40.4M | $49.6M | $45.6M | $46.7M | $60.6M | $33.2M | $31.2M | $34.9M | $33.5M |
| Income Tax Expense Benefit | $907.0K | $906.0K | $1.3M | $1.5M | $1.2M | $1.1M | $1.5M | $877.0K | $775.0K | $829.0K | $832.0K | $833.0K | $305.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.42B | $1.57B | $1.60B | $1.50B | $1.61B | $1.62B | $676.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $43.2M | $61.8M | $52.4M | $39.6M | $33.8M | $32.1M | $9.4M |
| Interest And Other Debt Expenses | $111.6M | $113.7M | $111.3M | $79.5M | $59.0M | $39.9M | |
| Gain Loss On Investments | -$62.2M | -$189.5M | -$50.7M | -$173.3M | -$44.6M | $66.2M | |
| Retained Earnings Accumulated Deficit | -$456.7M | -$373.7M | -$224.6M | -$206.2M | -$55.0M | -$5.4M | |
| Repayments Of Debt | $1.64B | $995.6M | $567.7M | $698.5M | $898.2M | $1.26B | |
| Distribution Made To Limited Liability Company LLC Member Cash Distributions Paid | $233.5M | $197.7M | $191.0M | $180.0M | $193.0M | $145.6M | |
| Accrued But Unpaid Excise Tax Expense | $4.3M | $6.0M | $5.1M | $3.5M | $1.4M | $1.6M | |
| Accrued But Unpaid Distributions | $36.0M | $52.8M | $49.3M | $46.3M | $45.8M | $45.7M | |
| Other Assets | $2.4M | $1.1M | $2.7M | $942.0K | $2.8M | ||
| Management Fee Payable | $8.2M | $8.8M | $8.7M | $9.1M | $8.4M | ||
| Long Term Debt | $1.87B | $1.93B | $1.83B | $2.01B | $1.86B | ||
| Liabilities And Stockholders Equity | $3.38B | $3.60B | $3.52B | $3.59B | $3.55B | ||
| Liabilities | $1.96B | $2.03B | $1.92B | $2.09B | $1.94B | ||
| Investment Owned Percent Of Net Assets | $2.29 | $2.21 | $2.13 | $2.33 | $2.15 | ||
| Interest And Other Debt Expenses Payable | $25.5M | $21.3M | $13.4M | $13.3M | $14.9M | ||
| Distribution Payable | $36.0M | $52.8M | $49.3M | $46.3M | $45.8M | ||
| Deferred Finance Costs Net | $8.2M | $8.2M | $5.4M | $8.7M | $12.3M | ||
| Deferred Costs | $13.2M | $11.9M | $14.9M | $12.8M | $12.6M | ||
| Common Stock Value | $113.0K | $117.0K | $110.0K | $103.0K | $102.0K | ||
| Assets | $3.38B | $3.60B | $3.52B | $3.59B | $3.55B | ||
| Additional Paid In Capital Common Stock | $1.88B | $1.95B | $1.83B | $1.71B | $1.67B | ||
| Accounts Payable And Other Accrued Liabilities Current | $8.6M | $12.1M | $9.1M | $7.1M | $5.3M | ||
| Exchange Of Investments | $111.0M | $204.2M | $119.6M | $153.3M | $9.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.45B | $1.51B | $1.55B | $1.59B | $1.60B | $1.63B | $1.60B | $1.60B | $1.58B | $1.54B | $1.59B | $1.61B | $1.62B | $1.63B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $115.2M | $108.0M | $82.8M | $53.0M | $61.6M | $52.3M | $76.6M | $42.4M | $47.2M | $32.7M | $44.8M | $31.4M | $171.6M | |
| Interest And Other Debt Expenses | $28.1M | $26.4M | $28.3M | $29.3M | $29.1M | $27.6M | $28.2M | $27.8M | $27.3M | $22.0M | $16.2M | $15.7M | $14.4M | |
| Gain Loss On Investments | -$20.6M | -$5.2M | -$18.0M | -$30.9M | -$121.4M | -$18.4M | -$21.3M | $1.3M | -$19.5M | -$68.8M | -$31.0M | -$9.8M | -$26.2M | |
| Retained Earnings Accumulated Deficit | -$454.3M | -$420.9M | -$398.4M | -$355.0M | -$339.3M | -$232.6M | -$208.7M | -$211.0M | -$227.4M | -$141.7M | ||||
| Repayments Of Debt | $529.0M | $491.0M | $147.0M | $129.0M | ||||||||||
| Distribution Made To Limited Liability Company LLC Member Cash Distributions Paid | $52.8M | $47.6M | $44.6M | $44.6M | ||||||||||
| Accrued But Unpaid Excise Tax Expense | $1.6M | $1.8M | $1.1M | -$190.0K | ||||||||||
| Accrued But Unpaid Distributions | $56.3M | $50.4M | $49.3M | $45.8M | ||||||||||
| Other Assets | $643.0K | $1.7M | $1.7M | $3.4M | $1.5M | $1.9M | $1.6M | $1.6M | $1.5M | $744.0K | ||||
| Management Fee Payable | $8.2M | $8.4M | $8.7M | $8.9M | $8.9M | $8.7M | $8.9M | $9.0M | $8.9M | $9.2M | ||||
| Long Term Debt | $1.84B | $1.80B | $1.87B | $1.88B | $1.94B | $1.83B | $1.88B | $1.96B | $1.94B | $2.10B | ||||
| Liabilities And Stockholders Equity | $3.39B | $3.41B | $3.50B | $3.55B | $3.63B | $3.55B | $3.56B | $3.64B | $3.61B | $3.71B | ||||
| Liabilities | $1.93B | $1.90B | $1.96B | $1.96B | $2.03B | $1.92B | $1.96B | $2.04B | $2.03B | $2.17B | ||||
| Investment Owned Percent Of Net Assets | $2.20 | $2.16 | $2.19 | $2.17 | $2.21 | $2.11 | $2.15 | $2.22 | $2.22 | $2.34 | ||||
| Interest And Other Debt Expenses Payable | $8.1M | $15.5M | $5.4M | $8.2M | $21.8M | $8.8M | $6.0M | $12.7M | $5.7M | $6.8M | ||||
| Distribution Payable | $54.8M | $55.9M | $56.3M | $52.7M | $52.5M | $50.4M | $49.3M | $49.3M | $49.3M | $46.3M | ||||
| Deferred Finance Costs Net | $9.6M | $5.7M | $6.9M | $9.7M | $11.5M | $13.0M | $6.3M | $7.1M | $7.9M | $9.6M | ||||
| Deferred Costs | $14.1M | $14.8M | $11.1M | $12.7M | $13.5M | $14.1M | $10.6M | $11.3M | $12.0M | $13.5M | ||||
| Common Stock Value | $114.0K | $116.0K | $117.0K | $117.0K | $117.0K | $112.0K | $110.0K | $109.0K | $109.0K | $103.0K | ||||
| Assets | $3.39B | $3.41B | $3.50B | $3.55B | $3.63B | $3.55B | $3.56B | $3.64B | $3.61B | $3.71B | ||||
| Additional Paid In Capital Common Stock | $1.91B | $1.93B | $1.95B | $1.94B | $1.94B | $1.87B | $1.81B | $1.81B | $1.81B | $1.69B | ||||
| Accounts Payable And Other Accrued Liabilities Current | $7.6M | $7.8M | $7.5M | $8.1M | $6.1M | $5.4M | $8.5M | $5.8M | $4.8M | $6.3M | ||||
| Exchange Of Investments | $70.7M | $59.5M | $18.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Debt | $1.59B | $1.10B | $378.5M | $846.2M | $1.13B | $1.29B |
| Net Cash Provided By Used In Operating Activities | $325.7M | $2.5M | $300.7M | $27.4M | -$29.9M | $165.8M |
| Net Cash Provided By Used In Financing Activities | -$344.5M | $7.1M | -$288.0M | -$21.7M | $31.7M | -$143.1M |
| Increase Decrease In Interest And Other Debt Expenses Payable | $4.2M | $7.6M | $173.0K | -$1.7M | $5.3M | $6.4M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.2M | $3.2M | $1.5M | $1.8M | -$62.0K | -$5.4M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $186.0K | -$171.0K | $62.0K | $147.0K | -$211.0K | $55.0K |
| Payments Of Debt Issuance Costs | $9.7M | $8.2M | $5.3M | $2.9M | $4.6M | $24.8M |
| Payments Of Stock Issuance Costs | $229.0K | $515.0K | $680.0K | $557.0K | ||
| Proceeds From Issuance Of Common Limited Partners Units | $109.9M | $98.1M | $14.0M | |||
| Proceeds From Disposition Of Investment Operating Activity | $1.15B | $822.5M | $508.1M | $571.0M | $1.54B | |
| Payments For Purchase Of Investment Operating Activity | $938.1M | $995.9M | $394.4M | $712.7M | $1.72B | |
| Increase Decrease In Other Operating Assets | $4.5M | -$1.1M | $1.2M | -$1.8M | $770.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Debt | $469.3M | $502.6M | $68.9M | $131.8M |
| Net Cash Provided By Used In Operating Activities | $133.9M | $7.0M | $32.3M | $39.3M |
| Net Cash Provided By Used In Financing Activities | -$113.0M | -$7.0M | -$24.7M | -$41.8M |
| Increase Decrease In Interest And Other Debt Expenses Payable | -$15.5M | -$5.8M | -$7.5M | -$5.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$4.4M | -$3.5M | -$2.3M | -$2.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $141.0K | -$73.0K | $11.0K | $89.0K |
| Payments Of Debt Issuance Costs | $329.0K | $7.4M | $115.0K | |
| Payments Of Stock Issuance Costs | $229.0K | $194.0K | $28.0K | |
| Proceeds From Issuance Of Common Limited Partners Units | $36.6M | $98.1M | ||
| Proceeds From Disposition Of Investment Operating Activity | $201.9M | $114.6M | $30.5M | |
| Payments For Purchase Of Investment Operating Activity | $112.4M | $139.0M | $43.0M | |
| Increase Decrease In Other Operating Assets | $589.0K | -$256.0K | $601.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $12.64 | $13.41 | $14.62 | $14.61 | $15.86 | $15.91 | $16.75 | $17.65 | $18.09 | $18.31 | $18.97 | $19.56 | $20.00 |
| Investment Company Investment Income Loss Per Share | $1.57 | $2.20 | $2.28 | $2.24 | $2.33 | $2.04 | $1.98 | $2.06 | $2.07 | $2.10 | $2.14 | $1.77 | |
| Weighted Average Limited Partnership Units Outstanding | 115.6M | 114.7M | 108.3M | 102.3M | 101.7M | 53.9M | |||||||
| Earnings Per Share Diluted | $1.03 | $0.55 | $1.81 | $0.54 | $1.89 | $3.26 | |||||||
| Earnings Per Share Basic | $1.03 | $0.55 | $1.81 | $0.54 | $1.89 | $3.26 | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 112.6M | 117.3M | 109.6M | 102.9M | 101.8M | ||||||||
| Common Stock Shares Issued | 112.6M | 117.3M | 109.6M | 102.9M | 101.8M | ||||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | |||||||||||||
| Investment Company Investment Income Loss Per Share | $0.40 | $0.38 | $0.42 | $0.58 | $0.59 | $0.55 | $0.67 | $0.59 | $0.46 | ||||
| Weighted Average Limited Partnership Units Outstanding | 114.4M | 117.2M | 117.3M | 116.9M | 114.4M | 110.1M | 109.5M | 109.5M | 104.6M | 102.4M | 102.0M | 101.9M | 101.7M |
| Earnings Per Share Diluted | $0.22 | $0.34 | $0.27 | $0.32 | $-0.47 | $0.39 | $0.47 | $0.60 | $0.27 | $-0.07 | $0.18 | $0.39 | $0.37 |
| Earnings Per Share Basic | $0.22 | $0.34 | $0.27 | $0.32 | $-0.47 | $0.39 | $0.47 | $0.60 | $0.27 | $-0.07 | $0.18 | $0.39 | $0.37 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 114.1M | 116.3M | 117.3M | 117.2M | 116.7M | 112.1M | 109.6M | 109.5M | 109.5M | 102.8M | |||
| Common Stock Shares Issued | 114.1M | 116.3M | 117.3M | 117.2M | 116.7M | 112.1M | 109.6M | 109.5M | 109.5M | 102.8M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Professional Fees | $3.3M | $5.0M | $3.5M | $3.5M | $3.3M | $2.5M |
| Partners Capital Account Period Increase Decrease | -$149.7M | -$29.1M | $99.4M | -$112.0M | -$741.0K | $939.0M |
| Partners Capital Account Distributions | $216.8M | $208.5M | $197.1M | $184.3M | $198.3M | $100.3M |
| Noninterest Expense Directors Fees | $828.0K | $828.0K | $823.0K | $833.0K | $934.0K | $640.0K |
| Net Investment Income | $185.6M | $257.9M | $252.1M | $228.6M | $237.4M | $109.9M |
| Incentive Fee Expense | $26.2M | $17.2M | $49.4M | $12.0M | $40.7M | $35.8M |
| Distribution Made To Limited Partner Distributions Declared Per Unit | $1.88 | $1.80 | $1.80 | $1.80 | $1.95 | $1.80 |
| Net Investment Income Before Taxes | $257.9M | $252.1M | $233.0M | $238.7M | $111.3M | |
| Net Unrealized Appreciation Depreciation From Foreign Currency Forward Contracts | $688.0K | -$242.0K | -$584.0K | $455.0K | -$388.0K | |
| Foreign Currency And Other Transactions Gain Loss Unrealized | $299.0K | -$4.5M | $4.0M | $4.6M | -$5.6M | |
| Foreign Currency And Other Transactions Gain Loss Realized | $5.2M | $404.0K | -$2.6M | $304.0K | $63.0K | |
| Realized Investment Gains Losses | -$123.1M | -$158.0M | -$71.8M | -$19.0M | $40.5M | -$43.8M |
| Interest Paid Net | $95.6M | $93.9M | $102.6M | $72.0M | $41.9M | $27.2M |
| Net Investment Income Limited Partnership Per Unit Diluted | $2.20 | $2.28 | $2.24 | $2.33 | ||
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $60.4M | -$36.1M | $20.6M | -$152.1M | -$84.4M | |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$122.6M | -$153.4M | -$71.4M | -$21.3M | $39.9M | |
| Payment In Kind Interest Capitalized | $33.6M | $55.1M | $32.4M | $20.9M | $17.1M | $6.6M |
| Investment Company Dividend Distribution | $216.8M | $208.5M | $197.1M | $184.3M | $198.3M | |
| Reinvestment Of Stockholder Distributions | $7.3M | $3.1M | $3.8M | $5.2M | $2.1M | |
| Investment Owned At Fair Value | $3.26B | $3.48B | $3.41B | $3.51B | $3.48B | |
| Investment Company Increase Decrease From Share Transaction | -$52.2M | $116.5M | $100.7M | $17.3M | $5.2M | |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $180.0M | $176.5M | $202.8M | $124.4M | $108.3M | |
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $0.00 | -$308.0K | -$575.0K | $239.0K | $409.0K | |
| Unrealized Gain Loss Investment And Derivative Operating After Tax | $64.7M | -$37.1M | $25.4M | -$155.5M | -$89.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $698.0K | $781.0K | $964.0K | $1.3M | $1.2M | $1.1M | $982.0K | $888.0K | $878.0K | $814.0K | $867.0K | $878.0K | $724.0K |
| Partners Capital Account Period Increase Decrease | -$58.6M | -$34.6M | -$24.8M | -$9.8M | -$35.7M | $29.8M | $3.7M | $16.4M | $78.1M | -$41.8M | -$24.3M | -$4.4M | -$11.4M |
| Partners Capital Account Distributions | $58.2M | $61.7M | $56.3M | $52.7M | $52.5M | $50.4M | $49.3M | $49.3M | $49.3M | $46.3M | $45.9M | $45.8M | $50.9M |
| Noninterest Expense Directors Fees | $206.0K | $207.0K | $207.0K | $207.0K | $207.0K | $207.0K | $204.0K | $208.0K | $207.0K | $209.0K | $204.0K | $203.0K | $234.0K |
| Net Investment Income | $45.3M | $44.5M | $49.6M | $68.2M | $67.0M | $60.9M | $72.9M | $64.5M | $48.0M | $61.2M | $49.6M | $50.2M | $64.3M |
| Incentive Fee Expense | $7.1M | $8.5M | $6.8M | $0.00 | $0.00 | $10.9M | $6.2M | $7.8M | $22.3M | $0.00 | $3.8M | $8.2M | $9.3M |
| Distribution Made To Limited Partner Distributions Declared Per Unit | $0.51 | $0.53 | $0.48 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | $0.50 |
| Net Investment Income Before Taxes | $46.2M | $45.4M | $50.9M | $69.7M | $68.2M | $61.9M | $74.5M | $65.4M | $48.8M | $62.0M | $50.4M | $51.0M | $64.6M |
| Net Unrealized Appreciation Depreciation From Foreign Currency Forward Contracts | -$89.0K | -$377.0K | $41.0K | $145.0K | $232.0K | -$88.0K | -$41.0K | -$35.0K | $22.0K | $24.0K | $122.0K | ||
| Foreign Currency And Other Transactions Gain Loss Unrealized | -$1.2M | -$2.8M | -$3.5M | $1.4M | $3.6M | -$2.0M | -$1.7M | $5.0M | $3.3M | $1.8M | $1.4M | ||
| Foreign Currency And Other Transactions Gain Loss Realized | $239.0K | $60.0K | $4.3M | $186.0K | -$10.0K | -$5.0K | $200.0K | -$1.6M | -$69.0K | -$779.0K | $69.0K | ||
| Realized Investment Gains Losses | -$44.5M | -$17.0M | -$36.3M | -$2.7M | |||||||||
| Interest Paid Net | $40.7M | $30.9M | $32.7M | $18.4M | |||||||||
| Net Investment Income Limited Partnership Per Unit Diluted | $0.40 | $0.38 | $0.42 | $0.58 | $0.59 | $0.55 | $0.67 | $0.59 | $0.46 | $0.60 | |||
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$26.0M | $75.8M | $26.2M | $52.9M | -$93.0M | -$1.6M | -$16.1M | $4.3M | $16.5M | ||||
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $5.4M | -$81.0M | -$44.2M | -$83.7M | -$28.4M | -$16.8M | -$5.2M | -$3.0M | -$36.1M | ||||
| Payment In Kind Interest Capitalized | $10.8M | $15.3M | $8.3M | $5.5M | |||||||||
| Investment Company Dividend Distribution | $58.2M | $61.7M | $56.3M | $52.7M | $52.5M | $50.4M | $49.3M | $49.3M | $49.3M | ||||
| Reinvestment Of Stockholder Distributions | $1.7M | $1.7M | $1.2M | ||||||||||
| Investment Owned At Fair Value | $3.20B | $3.26B | $3.38B | $3.44B | $3.52B | $3.44B | $3.44B | $3.55B | $3.51B | $3.62B | |||
| Investment Company Increase Decrease From Share Transaction | -$25.1M | -$12.1M | $5.8M | $71.0M | $37.8M | $1.4M | $99.2M | ||||||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $45.6M | $46.0M | $40.7M | $40.4M | $49.6M | $45.6M | $46.7M | $58.6M | |||||
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $47.0K | -$381.0K | $46.0K | $62.0K | $170.0K | $386.0K | |||||||
| Unrealized Gain Loss Investment And Derivative Operating After Tax | $27.5M | -$3.1M | $18.2M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.